Source: Annual Congress 2008 - Innovative treatments in sleep disordered breathing
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
T. Gentina, F. Fortin, B. Douay, J. M. Dernis, F. Herengt, J. C. Bout, C. Lamblin (Lille, France). The role of bi-level therapy in obstructive sleep apnoea. Eur Respir J 2008; 32: Suppl. 52, 381

Member's Comments

No comment yet.

Related content which might interest you: Non-CPAP therapies in obstructive sleep apnoea Source: Guideline 2011 Year: 2011 Role of CPAP treatment in elderly with moderate obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Ato-oxy as the first successful pharmacotherapy for obstructive sleep apnoea Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside Year: 2019 Hypercapnia and respiratory drive in obstructive sleep apnoea patients before and after CPAP treatment Source: Eur Respir J 2002; 20: Suppl. 38, 103s Year: 2002 Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 Control of breathing in obstructive sleep apnoea patients: Role of CPAP therapy Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 The velumount device for obstructive sleep apnoea Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 CPAP treatment for obstructive sleep apnoea syndrome after CPAP training term Source: Eur Respir J 2002; 20: Suppl. 38, 102s Year: 2002 Efficacy of a FOT-based auto-CPAP device for the treatment of obstructive sleep apnea Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options Year: 2018 CPAP therapy in idiopathic pulmonary fibrosis patients with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011 Nasal inflammation and compliance with nasal CPAP therapy in obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012 CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD Source: Eur Respir J 2010; 35: 132-137 Year: 2010 Auto-titrating CPAP for treating obstructive sleep apnoea, a bimodal response in males? Source: Eur Respir J 2006; 28: Suppl. 50, 409s Year: 2006 Prevalence of complex sleep apnea (CompSAS) during manual CPAP titration for obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Evaluation of a new automatic CPAP algorithm in the treatment of the obstructive sleep apnea syndrome Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 Respiratory failure in obstructive sleep apnea syndrome (OSAS)- is CPAP therapy alone adequate? Source: Eur Respir J 2005; 26: Suppl. 49, 111s Year: 2005 Efficacy of an automatic positive airway pressure system for treatment of obstructive sleep apnoea Source: Eur Respir J 2002; 20: Suppl. 38, 9s Year: 2002